Krebs Stephanie has filed 3 insider transactions across 1 company since November 2023.
Most recent transaction: a grant/award of 120000 shares of Sensei Biotherapeutics, Inc. ($SNSE) on February 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 25,117,238 | 9999.99% | 0.48% |
| Dec. 20, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 1,257,299 | 9999.99% | 9.54% |
| Nov. 1, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Krebs Stephanie | Chief Business Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |